SOPO(SH:600746)2021-10-21 16:00Financial Performance - The company's operating revenue for Q3 2021 was ¥1,938,453,637.03, representing a year-on-year increase of 90.10%[7] - The net profit attributable to shareholders for Q3 2021 reached ¥646,276,898.77, a significant increase of 1,344.87% compared to the same period last year[7] - The net profit attributable to shareholders after deducting non-recurring gains and losses for Q3 2021 was ¥640,280,343.30, reflecting a year-on-year increase of 1,579.30%[7] - The basic earnings per share for Q3 2021 was ¥0.5534, up 1,197.03% from the previous year[9] - The company's total revenue for Q3 2021 reached ¥5,856,746,411.79, a significant increase from ¥2,520,921,895.78 in Q3 2020, representing a growth of approximately 132.5%[27] - Operating profit for Q3 2021 was ¥2,518,133,541.86, compared to ¥68,916,516.47 in Q3 2020, indicating a substantial increase in profitability[31] - Net profit for Q3 2021 was ¥2,150,658,748.21, a significant rise from ¥53,230,905.28 in the same period last year, reflecting a growth of approximately 3950%[31] - The total comprehensive income for the period reached ¥2,162,864,358.78, an increase from ¥47,717,097.38 in the previous year[33] - Basic earnings per share (EPS) was reported at ¥1.9066, up by ¥0.0519 compared to the same period last year[33] Assets and Liabilities - The total assets as of the end of Q3 2021 amounted to ¥6,564,305,330.14, marking an increase of 84.12% compared to the end of the previous year[10] - The company's total assets amounted to ¥6,564,305,330.14, compared to ¥3,565,152,588.04 in the previous year, showing an increase of about 84%[27] - The total liabilities increased to ¥667,100,866.18 from ¥617,768,367.74, indicating a rise of approximately 8.5%[27] - Total liabilities amounted to 617,768,367.74, a decrease from 623,786,066.86[41] - Non-current liabilities totaled 41,367,409.70, down from 47,385,108.82[41] - The total equity increased to ¥5,897,204,463.96 from ¥2,947,384,220.30, reflecting a growth of approximately 100%[27] - Total equity reached 2,947,384,220.30, remaining unchanged[41] Cash Flow - The company reported a net cash flow from operating activities of ¥1,510,954,556.00 for the first nine months of 2021, an increase of 563.74% year-on-year[9] - Cash inflow from operating activities totaled ¥4,887,401,673.61, significantly higher than ¥2,320,636,123.69 in the previous year, marking an increase of approximately 110%[33] - The net cash flow from operating activities was ¥1,510,954,556.00, compared to ¥227,641,551.57 in the same period last year[33] - Cash outflow from investing activities amounted to ¥2,128,423,300.65, up from ¥542,319,615.78 in the previous year, indicating a substantial increase in investment activities[33] - The net cash flow from investing activities was negative at -¥1,328,599,584.28, compared to -¥324,301,518.93 in the previous year[33] - Cash inflow from financing activities was reported at ¥992,999,993.04, compared to ¥531,500,000.00 in the previous year, reflecting a growth of approximately 87%[35] - The net cash flow from financing activities was ¥582,191,266.73, a significant increase from ¥73,021,749.07 in the previous year[35] - The ending balance of cash and cash equivalents was ¥958,014,293.90, up from ¥118,293,181.90 in the previous year[35] Investments and Acquisitions - The company plans to acquire 100% equity of Jiangsu Dongpu New Materials Technology Co., Ltd. for an undisclosed amount, with the acquisition price based on an independent third-party valuation[18] - Following the acquisition, the company intends to increase the registered capital of Dongpu New Materials by RMB 70,000,000, raising it from RMB 30,000,000 to RMB 100,000,000[18] - The company has approved the establishment of a wholly-owned subsidiary with an investment of RMB 100,000,000 in the new materials industry park in Zhenjiang[18] - The company plans to purchase land use rights for at least 300 acres in the Zhenjiang New Materials Industry Park, with a budget not exceeding RMB 20,000,000[18] Research and Development - Research and development expenses for Q3 2021 were ¥176,173,009.98, up from ¥106,658,973.13 in Q3 2020, marking an increase of about 65%[27] Inventory and Receivables - The company's inventory as of September 30, 2021, was RMB 449,817,232.70, compared to RMB 307,551,697.19 at the end of 2020, reflecting an increase in stock levels[22] - The company reported accounts receivable of RMB 56,638,947.85, an increase from RMB 42,851,421.88 at the end of 2020[22]